BrightSpring Health Services, Inc. to Participate in Two Upcoming Investor Conferences
BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®
BrightSpring Health Services, Inc. (NASDAQ: BTSG) had its price target raised by analysts at Mizuho from $17.00 to $20.00. They now have an "outperform" rating on the stock.
BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
BrightSpring Health Services, Inc. (NASDAQ: BTSG) had its price target raised by analysts at UBS Group AG from $16.00 to $20.00. They now have a "buy" rating on the stock.